Halozyme Therapeutics
HALO
#2134
Rank
โ‚น643.37 B
Marketcap
โ‚น5,057
Share price
-0.55%
Change (1 day)
69.64%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): โ‚น142.84

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is โ‚น150.95. In 2022 the company made an earnings per share (EPS) of โ‚น128.40 a decrease over its 2021 EPS that were of โ‚น247.25.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น142.8411.25%
2022โ‚น128.40-48.07%
2021โ‚น247.25196.88%
2020โ‚น83.28-292%
2019-โ‚น43.38-9.09%
2018-โ‚น47.71-237.5%
2017โ‚น34.70-149.38%
2016-โ‚น70.27211.54%
2015-โ‚น22.56-52.73%
2014-โ‚น47.71-24.66%
2013-โ‚น63.3348.98%
2012-โ‚น42.51145%
2011-โ‚น17.35-64.29%
2010-โ‚น48.58-17.65%
2009-โ‚น58.999.68%
2008-โ‚น53.7993.75%
2007-โ‚น27.7633.33%
2006-โ‚น20.82-4%
2005-โ‚น21.69-3.85%
2004-โ‚น22.56-13.33%
2003-โ‚น26.0383.59%
2002-โ‚น14.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น16.48-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น471.01 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น444.18 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น161.36 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น275.90 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1,222 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA